Association of Xba I allele (Xba I 44kb) of the human cytochrome P-450dbI (CYP2D6) gene in Japanese patients with idiopathic Parkinson’s disease
- 1 January 1991
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplificationThe Lancet, 1990
- The dopamine transporter and cytochrome P450IID1 (debrisoquine 4-hydroxylase) in brain: Resolution and identification of two distinct [3H]GBR-12935 binding proteinsArchives of Biochemistry and Biophysics, 1990
- Depression of the Hepatic Cytochrome P-450 Monooxygenase System by the Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Basic & Clinical Pharmacology & Toxicology, 1989
- Xenobiotic and endobiotic inhibitors of cytochrome p-450dbl function, the target of the debrisoouine/sparteine type polymorphismBiochemical Pharmacology, 1988
- Characterization of the common genetic defect in humans deficient in debrisoquine metabolismNature, 1988
- Evidence for polymorphic oxidation of sparteine in Japanese subjects.British Journal of Clinical Pharmacology, 1987
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsClinical Pharmacology & Therapeutics, 1985
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.Proceedings of the National Academy of Sciences, 1977